Results 211 to 220 of about 159,767 (320)
Omecamtiv Mecarbil in Systolic Heart Failure: Clinical Efficacy and Future Directions of a Novel Myosin-Activating Inotropic Agent. [PDF]
CureusRamadan MM +4 more
europepmc +1 more source
Advanced Genetics, EarlyView.Here, causal relations are examined between 2940 plasma proteins and 19 cardiovascular diseases (CVD) using a human genetics‐based method. 218 proteins are found whose blood levels influence CVD risks, with about half being new discoveries and largely confirmed in an independent cohort.
Chen Li +13 more
wiley +1 more source
Molecular and Enzymatic Properties of Cardiac Myosin A as Compared with Those of Skeletal Myosin A
, 1963 J. Brahms, Cyril M. Kay
openalex +1 more source
Hydrogen ion buffers and enzymatic activity: Myosin B adenosinetriphosphatase [PDF]
, 1968 Richard A. Murphy, P.G. Koss
openalex +1 more source
Integrated single-cell functional-proteomic profiling reveals a shift in myofibre specificity in human nemaline myopathy: A proof-of-principle study. [PDF]
J PhysiolSeaborne RAE +9 more
europepmc +1 more source
Effects of Magnesium and Calcium on the Superprecipitation of Myosin B
, 1965 Shizuo WATANABE, Tsutomu Yasui
openalex +1 more source
Apical constriction requires patterned apical surface remodeling to synchronize cellular deformation. [PDF]
ElifeYamashita S, Ishihara S, Graner F.
europepmc +1 more source
Somatic cell reprogramming for Parkinson's disease treatment
Ibrain, Volume 11, Issue 1, Page 59-73, Spring 2025.The fundamental purpose of cell reprogramming to treat Parkinson's disease is to generate dopaminergic neurons (DAN) and do transplantation. There are two ways to accomplish this. One method is to induce cells into induced DA neurons (iDAN) directly or to induce cells into induced pluripotent stem cells and ultimately into iDAN in vitro. Another option
Xiaozhuo Li, Kevin Fang, Fengping Wang
wiley +1 more source